Assenagon Asset Management S.A. Ultragenyx Pharmaceutical Inc. Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 252,669 shares of RARE stock, worth $8.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

252,669

Previous 1,163,755 78.29%

Holding current value

$8.89 Million

Previous $42.3 Million 82.04%

% of portfolio

0.01%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	SELL	$26.31 - $41.44 $24 Million - $37.8 Million	-911,086 Reduced 78.29%	252,669 $7.6 Million
Q2 2025 Jul 11, 2025	BUY	$31.06 - $39.3 $29.4 Million - $37.3 Million	947,865 Added 439.05%	1,163,755 $42.3 Million
Q1 2025 Apr 15, 2025	BUY	$36.21 - $45.78 $5.31 Million - $6.71 Million	146,617 Added 211.65%	215,890 $7.82 Million
Q4 2024 Jan 14, 2025	SELL	$42.07 - $57.72 $3.2 Million - $4.4 Million	-76,160 Reduced 52.37%	69,273 $2.91 Million
Q3 2024 Oct 23, 2024	BUY	$40.21 - $59.36 $131,044 - $193,454	3,259 Added 2.29%	145,433 $8.08 Million
Q1 2024 Apr 24, 2024	SELL	$43.02 - $53.69 $15,788 - $19,704	-367 Reduced 0.26%	142,174 $6.64 Million
Q4 2023 Jan 17, 2024	SELL	$31.73 - $49.19 $2.17 Million - $3.36 Million	-68,380 Reduced 32.42%	142,541 $6.82 Million
Q3 2023 Nov 06, 2023	SELL	$34.92 - $46.66 $822,261 - $1.1 Million	-23,547 Reduced 10.04%	210,921 $7.52 Million
Q2 2023 Jul 25, 2023	SELL	$37.35 - $52.15 $6.71 Million - $9.37 Million	-179,759 Reduced 43.4%	234,468 $10.8 Million
Q1 2023 Apr 18, 2023	BUY	$36.99 - $48.71 $9.41 Million - $12.4 Million	254,408 Added 159.19%	414,227 $16.6 Million
Q4 2022 Jan 12, 2023	SELL	$33.72 - $46.33 $987,153 - $1.36 Million	-29,275 Reduced 15.48%	159,819 $7.4 Million
Q3 2022 Oct 27, 2022	BUY	$39.96 - $66.14 $7.14 Million - $11.8 Million	178,744 Added 1727.0%	189,094 $7.83 Million
Q2 2022 Jul 27, 2022	BUY	$45.8 - $85.4 $474,029 - $883,890	10,350 New	10,350 $617,000
Q1 2022 Apr 25, 2022	SELL	$62.2 - $84.4 $650,238 - $882,317	-10,454 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$73.71 - $87.86 $99,213 - $118,259	1,346 Added 14.78%	10,454 $879,000
Q3 2021 Oct 19, 2021	BUY	$77.92 - $102.4 $709,695 - $932,659	9,108 New	9,108 $821,000
Q1 2021 Apr 26, 2021	SELL	$106.9 - $167.73 $6.4 Million - $10 Million	-59,891 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$84.4 - $177.39 $5.05 Million - $10.6 Million	59,891 New	59,891 $8.29 Million

Others Institutions Holding RARE

# of Institutions

362

Shares Held

88.2M

Call Options Held

3.64M

Put Options Held

2.24M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.46B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Ultragenyx Pharmaceutical Inc. Transaction History